Matthew Collingridge is starting a new position as GM Performance Partnerships Europe at Beckman Coulter Diagnostics. 


He will be responsible for the commercial leadership of Beckman Coulter Performance Partnership across Europe. Performance Partnerships catalyse the transformation of clinical laboratories into high-performing organisations through an integrated approach that brings people, instrumentation and data pathways together to create new opportunities for value, growth and innovation.


Matthew has over 15 years of healthcare experience in startups, and commercial and corporate management roles, across the UK, Australia and the Asia Pacific, Matthew’s extensive experience have focused on the intersect of technology, building and clinical services within mature and emerging health systems.


He believes that modern healthcare should encompass integrated care (and funding) through public and private collaboration, enabled by data, technology, risk transfer and innovation.


He is a graduate of Birmingham University, UK and relocated with his family from Singapore to Canada in July 2016.

«« FDA Approves COVID-19 Vaccine for Children Under Five


Combatting the Opioid Crisis »»



Latest Articles

Matthew Collingridge,GM Performance Partnerships Europe,Beckman Coulter Diagnostics. Matthew Collingridge is starting a new position as GM Performance Partnerships Europe at Beckman Coulter Diagnostics.